← All trials
NCT02465125
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2015
- Primary completion
- Dec 8, 2016
- Completion date
- Jan 9, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 58
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Naestved HospitalLead sponsor
- Research Unit, Naestved, Region Zealand, Denmark.Collaborator
- University of Southern DenmarkOverall official - principal investigator
- University of Southern DenmarkReponsible party - principal investigator
- University of CopenhagenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.